Lede: Traces of ancient viral DNA, embedded in the human genome for millions of years, have been directly linked to an elevated risk of developing certain cancers, according to a groundbreaking new study published on Wednesday in the journal Science Advances. Researchers at the University of Colorado Boulder found that these “fossil viruses”—known as endogenous retroviruses—can act as genetic switches, spurring the growth of malignant tumors when they are reactivated.
Body:
For decades, scientists have known that approximately eight percent of the human genome consists of remnants of ancient viruses that infected our primate ancestors. These genetic echoes were long considered inert “junk DNA.” The new research demonstrates that one specific sequence, ERV-9, is not dormant. In lab experiments and tissue samples from thousands of patients, it was found to be active in a range of cancers, including lung, breast, and colon.
“Think of these viral fragments as dormant embers,” said Dr. Edward Chuong, a lead author of the study. “Under the right conditions—often during aging or exposure to carcinogens—they can spark a fire, driving genes that are critical for tumor growth.”
Dr. Chuong and his team analyzed genomic data from over 10,000 cancer patients, comparing the expression levels of endogenous retroviruses with patient outcomes. The data revealed that individuals with high activity of ERV-9 in their tumor cells had a 30% lower five-year survival rate compared to those with low activity.
The mechanism is subtle. ERV-9 contains DNA sequences that bind to proteins that regulate gene expression. When the virus piece is activated, it can hijack the cell’s machinery to turn on nearby cancer-promoting genes, specifically those involved in cell division and metastasis. This process is not a direct cause of all cancers, but it acts as an accelerant in tumors triggered by other mutations.
This finding challenges conventional oncology. Traditional cancer treatments target specific mutations in a patient’s own DNA. These ancient viruses are foreign elements, meaning they may offer a unique target.
What This Means for Patients and Future Treatments
The discovery opens a new avenue for early detection. Simple blood tests, or liquid biopsies, are already being developed to detect the presence of active viral RNA from ERV-9. A positive readout could serve as a red flag for aggressive disease, potentially years before a tumor is visible on imaging.
More promising are the implications for therapy. Because these viral sequences are unique to the genome and are not typically expressed in healthy adult cells, they present a potential Achilles’ heel for cancer.
- Immunotherapy: The body’s immune system can be trained to recognize cells that display these viral proteins. Researchers are exploring “therapeutic vaccines” that prompt the immune system to attack tumor cells bearing ERV-9 markers.
- Epigenetic drugs: Because the virus is silenced by specific molecular “off switches” in healthy cells, drugs that re-apply those switches (HDAC inhibitors) are being tested to shut the viral genes back down.
“We are now looking at cancer not just as a disease of our own genes, but as a disease of our forgotten viral history,” explained Dr. Chuong.
Broader Impact and Next Steps
This research adds to a growing body of evidence that ancient viral elements play a significant role in human health, from pregnancy (where they help form the placenta) to neurodegeneration. The team at Colorado is currently screening thousands of existing drug compounds to see which ones can best silence ERV-9 without harming surrounding healthy tissue.
Human trials for a targeted ERV-9 vaccine are estimated to begin within the next three to five years, pending regulatory approval. For now, the study provides a clearer biological roadmap for understanding why some tumors are particularly aggressive.
For the public, the key takeaway is this: While we cannot change the ancient viral code written in our DNA, the ability to detect its activation could provide a powerful new tool in the fight against cancer. As Dr. Chuong puts it, “We are learning how to turn off a threat that has been hiding inside us for 30 million years.”
